Literature DB >> 599075

The proportion of hypoxic cells in a human tumor.

J Denekamp, J F Fowler, S Dische.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 599075     DOI： 10.1016/0360-3016(77)90140-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

1.  The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation.

Authors:  Frank Pajonk; Thorsten Grumann; William H McBride
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

2.  Oxygen distributions partly explain the radiation response of human squamous cell carcinomas.

Authors:  P Okunieff; J de Bie; E P Dunphy; D J Terris; M Höckel
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 3.  F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

Review 4.  Is any single in situ assay of tumour response adequate?

Authors:  J Denekamp
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Is tumour radiosensitization by misonidazole a general phenomenon?

Authors:  J Denekamp; D G Hirst; F A Stewart; N H Terry
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

6.  The quantitative response of human tumours to radiation and misonidazole.

Authors:  D V Ash; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.